Status:

COMPLETED

A Study to Assess the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol Hydrochloride and Acetaminophen

Lead Sponsor:

Janssen Korea, Ltd., Korea

Conditions:

Chronic Pain

Eligibility:

All Genders

20+ years

Brief Summary

The purpose of this study is to evaluate the impact of extended release tramadol hydrochloride (75 mg) and acetaminophen (650 mg) tablets on improvement of pain.

Detailed Description

This is a multi-center (study conducted at multiple sites), open label (all people know the identity of the intervention), prospective (in which the participants are first identified and then followed...

Eligibility Criteria

Inclusion

  • Patients with the prescription of ULTRACET ER for the treatment of moderate to severe pain
  • Complaining of chronic pain for more than 3 months

Exclusion

  • Patient who had been treated with extended release tramadol hydrochloride (75mg) and acetaminophen (650mg) or strong opioids (eg, morphine, fentanyl, oxycodone, hydromorphone) within the past 4 weeks
  • Patient with a severe mental disease and with a medical history of hypersensitivity to opioid analgesics
  • Pregnant females or the females likely to become pregnant during the study period
  • Patient who had been believed likely to complain of more pain than the real pain he or she is experiencing because of industrial disaster, car insurance, and others
  • Patients who are contraindicated according to the warnings, precautions and prohibitions regarding extended release tramadol hydrochloride (75mg) and acetaminophen (650mg)

Key Trial Info

Start Date :

September 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

July 1 2012

Estimated Enrollment :

1065 Patients enrolled

Trial Details

Trial ID

NCT01819805

Start Date

September 1 2011

End Date

July 1 2012

Last Update

January 1 2015

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

Busan, South Korea

2

Cheonan, South Korea

3

Chungcheongbuk-Do, South Korea

4

Chungju, South Korea